GENE ONLINE|News &
Opinion
Blog

Innovation
Trials & Approvals Cystic Fibrosis
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
COVID-19 Mutation
New COVID-19 Variant: Vaccine Makers Optimistic but Experts are Cautious over Unique Mutations
2020-12-24
Anti-tumor Drugs
Bayer’s New Anti-Tumor Drug BAY 2416964 Receives Approval for Clinical Use in China
2020-12-23
Trials & Approvals
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
Startups
Taiwanese Startup, Micronbrane Aims to Improve Detection of Microbial Pathogens
2020-12-21Partner
Roche
Roche’s Cobas PIK3CA Mutation Test – A Blessing for Breast Cancer Patients
2020-12-20
Startups lipid production
Ginkgo Acquires Bioengineering Assets of Massachusetts-Based Biotech Startup
2020-12-20
Technology CRISPR
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
Gene Editing
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
Technology CRISPR
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
In-Depth Gut Microbiota
Spotlight: How Does the Human Gut Microbiota Affect Immune Cell Dynamics?
2020-12-15
R&D Proteasome
SK Holdings Supports Roivant’s New Protein Degradation Platform with US$ 200 Million Investment
2020-12-13
R&D
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
In-Depth Protein Structure
Spotlight: Alphafold Maybe This Century’s Biggest Breakthrough in Computational Biology
2020-12-11
1 … 34 35 36 37 38 … 58
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top